Brief: Eisai Projects Leqembi® Revenue To Total JPY 76.5 Billion For FY 2025
15/05/2025 06:14
May 15 (Reuters) - BioArctic AB BIOAb.ST: EISAI PROJECTS LEQEMBI® REVENUE TO TOTAL JPY 76.5 BILLION FOR FISCAL YEAR 2025 (APRIL 2025 - MARCH 2026) BIOARCTIC AB - EXPECTED TO RECEIVE SEK 510 M IN ROYALTY FROM LEQEMBI SALES Source text: ID:nWkr2CvvfT Further company coverage: [BIOAb.ST] ((Reuters.Briefs@thomsonreuters.com;))
Recent news on BioArctic AB
See all newsBrief: BioArctic And Lilly Sign Research, Collaboration Agreement
Brief: Bioarctic AB Declares Dividend Of Sek 2 Per Share With 1 June 2026 Record Date
Brief: Bioarctic Partner Eisai Presents Leqembi Sales Simulation
Sweden's BioArctic Q1 revenue drops sharply despite higher Leqembi royalties
Brief: BioArctic Q1 Operating Profit SEK 210.8 Million